Search Results for: ustr

The July 20, 2009 issue of BioCentury has an extensive report on the “Biosimilar fire Drill.” It discusses in detail the lobbying by the Biotechnology Industry Association (BIO, bio.org) to defeat efforts by President Obama, OMB, the FTC, Representative Waxman, Senator Brown, AARP, Public Citizen, PIRG, Consumers Union, KEI, Essential Action, and others, to reform the regulation to biologic medicines, so there is more generic competition. Continue Reading →

*The author thanks Professor Marc Perlman (Brown University) for his comprehensive notes on the IGC deliberations.

Continue Reading →

TACD has issued a resolution on copyright terms, and measures to mitigate the harm from excessive terms. The TACD Press release follows:

Continue Reading →

Today nine NGOs sent a letter the WHO Expert Working Group on R&D Financing. The letter focuses on issues about transparency, conflicts of interest, and EWG outcomes. The whole EWG seems to be going very badly right now, in part because of the US government and much of Northern Europe is working hand and glove with the pharmaceutical industry, and partly because the Gates Foundation is protecting big pharma and seems to have an ideological attachment to strong IPR.

Continue Reading →

The US Department of State “2009 Investment Climate Statement for Switzerland” provides an interesting and often unexpected portrait of the intellectual property landscape for a country that is often a hard-liner in global IPR negotiations. Continue Reading →

I just finished a two day meeting in Manchester, England, in a meeting of Joe Stigltiz’s Initiative for Policy Dialogue (IPD) Task Force on Intellectual Property and Development. The meeting was held at the University of Manchester’s Brooks World Poverty Institute. The agenda and conference papers for the meeting are on the web here, including a paper on prizes I wrote with Tim Hubbard. Continue Reading →

Our impressions about this appointment are positive, but we would like to hear from others. IBM has been very smart on IPR issues lately, recognizing that knowledge is often more valuable when shared. Coming from a successful technology firm, he will have both credibility and insight into innovation policy. He brings more balance to the job than anyone we can remember. Below are some interesting quotes from various articles.

Continue Reading →